All In Biotech

Drug Trial Radar · NCT01450761

Trial in Extensive-Disease Small Cell Lung Cancer (ED-SCLC) Subjects Comparing Ipilimumab Plus Etoposide and Platinum Therapy to Etoposide and Platinum Therapy Alone

Randomized, Multicenter, Double-Blind, Phase 3 Trial Comparing the Efficacy of Ipilimumab Plus Etoposide/Platinum Versus Etoposide/Platinum in Subjects With Newly Diagnosed Extensive-Stage Disease Small Cell Lung Cancer (ED-SCLC)

Last checked: Nov 20, 2026Latest source record: Jul 8, 2020 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 1,351 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

1,351

Actual

Start

Dec 13, 2011

Primary completion

Mar 19, 2015

Study completion May 17, 2017

Sponsor

Lead sponsor
Bristol-Myers SquibbBristol Myers Squibb (BMY)
Sponsor type
Industry
First posted
Oct 12, 2011

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of the study is to determine whether the addition of Ipilimumab to Etoposide and Platinum therapy will extend the lives of patients with Extensive-Stage Disease Small Cell Lung Cancer (ED-SCLC) more than Etoposide and Platinum therapy alone.

Conditions

  • Small Cell Lung Carcinoma

Interventions

  • IpilimumabBiological

  • Placebo matching IpilimumabBiological

  • EtoposideDrug

  • CisplatinDrug

  • CarboplatinDrug

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Overall Survival (OS) in Participants Who Received at Least One Dose of Blinded Study TherapyTime frame: Randomization until date of death, up to March 2015, approximately 38 months

Locations

225 sites in 34 countries. Site status is shown where the registry gives one.

  • Genesis Cancer Center

    Hot Springs, Arkansas

  • Sutter Medical Center

    Auburn, California

  • UCSD Moores Cancer Center

    La Jolla, California

  • University Of Colorado Cancer Center

    Aurora, Colorado

  • Florida Cancer Specialists S.

    Fort Myers, Florida

  • Cancer Specialists, LLC

    Jacksonville, Florida

  • Lake City Cancer Care

    Lake City, Florida

  • Florida Cancer Specialists

    St. Petersburg, Florida

  • Medical Oncology, LLC

    Augusta, Georgia

  • Quincy Medical Group

    Quincy, Illinois

  • Presence Medical Group Hematology Oncology

    Skokie, Illinois

  • SIU School Of Medicine

    Springfield, Illinois

  • St. Francis Medical Group Oncology And Hematology Specialist

    Indianapolis, Indiana

  • Cancer Center Of Kansas

    Wichita, Kansas

  • Ashland Bellefonte Cancer Center

    Ashland, Kentucky

  • University Of Kentucky

    Lexington, Kentucky

  • Montgomery Cancer Center

    Mount Sterling, Kentucky

  • St Joseph Mercy Hospital

    Ypsilanti, Michigan

  • St. Luke'S Cancer Institute

    Kansas City, Missouri

  • Southeast Nebraska Hematology & Oncology Consultants, P.C.

    Lincoln, Nebraska

  • Regional Cancer Care Associates, LLC/Cherry Hill Division

    Cherry Hill, New Jersey

  • Memorial Sloan Kettering Nassau

    New York, New York

  • Gabrail Cancer Center

    Canton, Ohio

  • Oncology Hematology Care, Incorporated

    Cincinnati, Ohio

  • University Hospitals

    Cleveland, Ohio

  • Signal Point Clinical Research Center, Llc

    Middletown, Ohio

  • Oklahoma Cancer Specialists and Research Institute, LLC

    Tulsa, Oklahoma

  • Providence Portland Medical Center

    Portland, Oregon

  • Kaiser Permanente

    Portland, Oregon

  • Chattanooga Oncology Hematology Associates

    Chattanooga, Tennessee

  • Associated in Oncology and Hematology

    Chattanooga, Tennessee

  • The Jones Clinic, PC

    Germantown, Tennessee

  • Tennessee Cancer Specialists

    Knoxville, Tennessee

  • Thompson Cancer Survival Center

    Knoxville, Tennessee

  • Tennessee Oncology, PLLC

    Nashville, Tennessee

  • Henry-Joyce Cancer Center

    Nashville, Tennessee

  • University Of Texas, M. D. Anderson Cancer Center

    Houston, Texas

  • Joe Arrington Cancer Research And Treatment Center

    Lubbock, Texas

  • Huntsman Cancer Hospital

    Salt Lake City, Utah

  • Virginia Cancer Institute

    Richmond, Virginia

Showing 40 of 225 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.